These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 968783)

  • 41. [Prevention and therapy of hepatic coma].
    Szám I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):65-8. PubMed ID: 5501431
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical trial of ornithine alpha ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14(4):Suppl 3:512-5. PubMed ID: 5355632
    [No Abstract]   [Full Text] [Related]  

  • 45. [On a combination of amino acids and vitamins in the treatment of liver diseases].
    Bazzicalupo G; Pietranera P
    Minerva Med; 1967 Apr; 58(34 Suppl):1587-92. PubMed ID: 4226043
    [No Abstract]   [Full Text] [Related]  

  • 46. Intravenous loading with arginine-hydrochloride and ornithine-aspartate in siblings of two families, presenting a familial neurological syndrome associated with cystinuria.
    Strauven T; Mardens Y; Clara R; Terheggen H
    Biomedicine; 1976 Jun; 24(3):191-9. PubMed ID: 990372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Betaine aspartate in the hepato-digestive domain].
    Cachin M; Pergola F
    Sem Ther; 1966 Oct; 42(8):423-4. PubMed ID: 5994378
    [No Abstract]   [Full Text] [Related]  

  • 48. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 49. [Biochemical mechanisms of action of catalyzers of ureogenesis and their use in human therapy].
    Salvatore F; Cimino F
    Recenti Prog Med; 1976 Aug; 61(2):179-210. PubMed ID: 1037141
    [No Abstract]   [Full Text] [Related]  

  • 50. [Association of vitamins and amino acids in the therapy of chronic liver diseases. Clinical results].
    Miracco A; Orlando V
    Minerva Med; 1967 Apr; 58(34 Suppl):1620-6. PubMed ID: 4226050
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pathogenesis and therapy of exogenous hepatic coma].
    Leonhardt H
    Fortschr Med; 1973 Jan; 91(1):35-8. PubMed ID: 4699340
    [No Abstract]   [Full Text] [Related]  

  • 52. [Metabolism of ammonia and its disorders; therapeutic importance of aspartic acid salts (outline of an experimental and clinical study)].
    LABORIT H; WEBER B; JOUANY J; NIAUSSAT P; BARON C
    Presse Med (1893); 1958 Dec; 66(93):2125-8. PubMed ID: 13633785
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical considerations on the use of a new preparation with hepatoprotective action].
    Di Lorenzo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1626-9. PubMed ID: 4226051
    [No Abstract]   [Full Text] [Related]  

  • 54. [Radiophysical studies: irradiation of ornithine aspartate in the Siemens training reactor SUR 100].
    Szirmai J; Knapp J; Keinert J
    Acta Oncol (Madr); 1969; 8(2):172-4. PubMed ID: 5385130
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A
    Minerva Med; 1967 Apr; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract]   [Full Text] [Related]  

  • 56. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperammoniemia. Inborn metabolic disorder of the ornithine cycle. I. Diagnostic problems].
    Vulovic D; Joksimovic I; Subotic Z; Hajdukovic R; Vuckovic M; Levin B; Dobbs R
    Srp Arh Celok Lek; 1973; 101(3):201-16. PubMed ID: 4786871
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical experimentation with a new preparation: Polilevo].
    Floris E; Mura B
    Minerva Med; 1967 Apr; 58(34 Suppl):1633-4. PubMed ID: 4226053
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of potassium & magnesium salts of DL-aspartic acid on the hyperammoniemia of experimental hemorrhagic shock].
    LABORIT H; OBRENOVITCH L; LEGUEN P; JOUANY JM
    C R Seances Soc Biol Fil; 1958; 152(6):942-4. PubMed ID: 13609089
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the therapeutic value of some amino acids in combination with vitamin B 12, folic acid and nicotinamide in the therapy of hepatic insufficiency].
    Meneghini P; Avanzi G
    Minerva Med; 1967 Apr; 58(34 Suppl):1596-603. PubMed ID: 4226045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.